Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Glavac

A Polymorphism in the TC21 Promoter Associates With an Unfavorable Tamoxifen Treatment Outcome in Breast Cancer

Cancer Research

Cancer Research

English

Related publications

TSC22D1 and PSAP Predict Clinical Outcome of Tamoxifen Treatment in Patients With Recurrent Breast Cancer

Breast Cancer Research and Treatment

Cancer Research

English

Association of Osteopontin Promoter Polymorphism and Aggresivness in Breast Cancer

Sohag Medical Journal

English

Impact of UGT2B7 His268Tyr Polymorphism on the Outcome of Adjuvant Epirubicin Treatment in Breast Cancer

Breast Cancer Research

Cancer Research

English

Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy

Breast Cancer Research and Treatment

Cancer Research

English

CYP2D6 Genotyping and Tamoxifen in the Treatment of Post-Menopausal Breast Cancer - A Reply

British Journal of Clinical Pharmacology

English

LRG1 mRNA Expression in Breast Cancer Associates With PIK3CA Genotype and With Aromatase Inhibitor Therapy Outcome

Molecular Oncology

Cancer Research

Molecular Medicine

English

Risk of Endometrial Cancer After Tamoxifen Treatment of Breast Cancer

English

The C1772T Genetic Polymorphism in Human HIF-1α Gene Associates With Expression of HIF-1α Protein in Breast Cancer

Oncology Reports

Cancer Research

English

Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation With Worse Outcome in Breast Cancer Patients

Clinical Cancer Research

Cancer Research

English